Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer
Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer
Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer
Submitted by
admin
on October 4, 2017 - 11:23am
Source:
Endpoints
News Tags:
Amgen
Immatics
T-cells
Headline:
Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer
Do Not Allow Advertisers to Use My Personal information
